Investor Toolkit

Press Release

Lantheus to Host Second Quarter 2014 Conference Call on August 12, 2014 at 4:30 p.m. Eastern Time

N. Billerica, Mass., August 5, 2014 – Lantheus Medical Imaging, Inc. (Lantheus) today announced that it will host a conference call at 4:30 p.m. ET on Tuesday, August 12, 2014, to discuss its financial and operating results for the second quarter of 2014.

To access the live conference call via telephone, please dial 1-866-510-0712 (U.S. callers) or 1‑617-597-5380 (international callers) and provide passcode 37835042. A live audio webcast of the call also will be available on the homepage of the Company's website at www.lantheus.com.

A replay of the telephone conference call and audio webcast will be available from approximately 6:30 p.m. ET on August 12, 2014 through midnight on August 25, 2014. To access a replay of the conference call, dial 1-888-286-8010 (U.S. callers) or 1-617-801-6888 (international callers), and provide passcode 62046667.

About Lantheus Medical Imaging, Inc.
Lantheus Medical Imaging, Inc. is a global leader in developing, manufacturing, selling and distributing innovative diagnostic imaging agents. The Company provides a broad portfolio of products, which are primarily used for the diagnosis of cardiovascular diseases. Lantheus key products include the echocardiography contrast agent DEFINITY® Vial for (Perflutren Lipid Microsphere) Injectable Suspension; TechneLite® (Technetium Tc99m Generator), a technetium-based generator that provides the essential medical isotope used in nuclear medicine procedures; and Xenon (Xenon Xe 133 Gas), an inhaled radiopharmaceutical imaging agent used to evaluate pulmonary function and for imaging the lungs.

Lantheus has more than 500 employees worldwide with headquarters in North Billerica, Massachusetts, and offices in Puerto Rico, Canada and Australia.For more information, visit www.lantheus.com.